CN103547680B - 用于确定牙周病的严重性和进展的改进方法和试剂盒 - Google Patents
用于确定牙周病的严重性和进展的改进方法和试剂盒 Download PDFInfo
- Publication number
- CN103547680B CN103547680B CN201180067082.6A CN201180067082A CN103547680B CN 103547680 B CN103547680 B CN 103547680B CN 201180067082 A CN201180067082 A CN 201180067082A CN 103547680 B CN103547680 B CN 103547680B
- Authority
- CN
- China
- Prior art keywords
- il1b
- allele
- patient
- periodontal disease
- il1b3877
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/18—Dental and oral disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42162810P | 2010-12-09 | 2010-12-09 | |
| US61/421628 | 2010-12-09 | ||
| US201161452157P | 2011-03-13 | 2011-03-13 | |
| US61/452157 | 2011-03-13 | ||
| PCT/US2011/064216 WO2012079010A2 (en) | 2010-12-09 | 2011-12-09 | Improved method and kit for determining severity and progression of periodontal disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103547680A CN103547680A (zh) | 2014-01-29 |
| CN103547680B true CN103547680B (zh) | 2017-05-24 |
Family
ID=46207769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201180067082.6A Expired - Fee Related CN103547680B (zh) | 2010-12-09 | 2011-12-09 | 用于确定牙周病的严重性和进展的改进方法和试剂盒 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20120208187A1 (enExample) |
| EP (1) | EP2649203B1 (enExample) |
| JP (2) | JP6138692B2 (enExample) |
| CN (1) | CN103547680B (enExample) |
| AU (2) | AU2011338210B2 (enExample) |
| BR (1) | BR112013014479B1 (enExample) |
| NZ (2) | NZ701432A (enExample) |
| RU (2) | RU2018122965A (enExample) |
| SG (1) | SG191078A1 (enExample) |
| WO (1) | WO2012079010A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106918706B (zh) * | 2015-12-25 | 2019-05-21 | 广州瑞博奥生物科技有限公司 | 一种检测牙周病相关蛋白的抗体芯片试剂盒 |
| CA3011363A1 (en) | 2016-01-12 | 2017-07-20 | Interleukin Genetics, Inc. | Methods for predicting response to treatment |
| US10329620B2 (en) | 2017-01-12 | 2019-06-25 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| GB201818627D0 (en) * | 2018-11-15 | 2019-01-02 | Mars Inc | Analytical systems |
| JP7097855B2 (ja) * | 2019-04-24 | 2022-07-08 | ジェネシスヘルスケア株式会社 | 歯周病のリスクを判定する方法 |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
| KR102571131B1 (ko) * | 2021-06-01 | 2023-08-24 | 부산대학교 산학협력단 | 치주염 감별용 바이오마커 조성물, 치주염 중증도 감별용 바이오마커 조성물, 및 이를 이용한 진단 키트 |
| EP4430621A1 (en) * | 2021-11-12 | 2024-09-18 | Mars, Incorporated | Systems and methods for generating health reports based on veterinary oral care health test |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005108619A2 (en) * | 2004-05-03 | 2005-11-17 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110920A (en) | 1982-01-22 | 1992-05-05 | Cetus Corporation | HLA typing method and DNA probes used therein |
| US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5268267A (en) | 1987-08-21 | 1993-12-07 | The General Hospital Corporation | Method for diagnosing small cell carcinoma |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5328829A (en) | 1990-07-05 | 1994-07-12 | Forsyth Dental Infirmary For Children | Method of determining sites of active periodontal disease |
| US5686246A (en) * | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| US20050282198A1 (en) * | 1997-05-29 | 2005-12-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| US6130042A (en) * | 1998-03-05 | 2000-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for diagnosing periodontal disease |
| US20080118920A1 (en) * | 2004-05-03 | 2008-05-22 | Duff Gordon W | Diagnostics And Therapeutics For Diseases Associated With An Il-1 Inflammatory Haplotype |
| EP2304052A2 (en) * | 2008-05-02 | 2011-04-06 | Interleukin Genetics, Inc. | Detecting genetic predisposition to osteoarthritis associated conditions |
-
2011
- 2011-12-09 SG SG2013044383A patent/SG191078A1/en unknown
- 2011-12-09 CN CN201180067082.6A patent/CN103547680B/zh not_active Expired - Fee Related
- 2011-12-09 RU RU2018122965A patent/RU2018122965A/ru not_active Application Discontinuation
- 2011-12-09 BR BR112013014479-3A patent/BR112013014479B1/pt not_active IP Right Cessation
- 2011-12-09 NZ NZ701432A patent/NZ701432A/en not_active IP Right Cessation
- 2011-12-09 WO PCT/US2011/064216 patent/WO2012079010A2/en not_active Ceased
- 2011-12-09 US US13/316,198 patent/US20120208187A1/en not_active Abandoned
- 2011-12-09 RU RU2013131239A patent/RU2664431C2/ru not_active IP Right Cessation
- 2011-12-09 AU AU2011338210A patent/AU2011338210B2/en not_active Ceased
- 2011-12-09 EP EP11846577.2A patent/EP2649203B1/en not_active Not-in-force
- 2011-12-09 NZ NZ612799A patent/NZ612799A/en not_active IP Right Cessation
- 2011-12-09 JP JP2013543383A patent/JP6138692B2/ja active Active
-
2013
- 2013-08-08 US US13/962,637 patent/US9347090B2/en active Active
-
2016
- 2016-04-08 AU AU2016202211A patent/AU2016202211B2/en not_active Ceased
- 2016-05-02 US US15/144,263 patent/US20160244841A1/en not_active Abandoned
-
2017
- 2017-01-20 JP JP2017008513A patent/JP6622731B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005108619A2 (en) * | 2004-05-03 | 2005-11-17 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
Non-Patent Citations (1)
| Title |
|---|
| Novel interleukin 1βpolymorphism increased the risk of gastric cancer in a Korean population;Kyung-A Lee,et al;《J Gastroenterol》;20041231;第39卷;429-433 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6138692B2 (ja) | 2017-05-31 |
| JP2017121237A (ja) | 2017-07-13 |
| JP6622731B2 (ja) | 2019-12-18 |
| EP2649203A2 (en) | 2013-10-16 |
| AU2016202211B2 (en) | 2017-02-23 |
| EP2649203A4 (en) | 2014-05-07 |
| CN103547680A (zh) | 2014-01-29 |
| AU2016202211A1 (en) | 2016-05-05 |
| AU2011338210A1 (en) | 2013-07-25 |
| WO2012079010A2 (en) | 2012-06-14 |
| RU2018122965A3 (enExample) | 2019-04-11 |
| BR112013014479A2 (pt) | 2016-09-20 |
| JP2013544536A (ja) | 2013-12-19 |
| RU2013131239A (ru) | 2015-01-20 |
| US20120208187A1 (en) | 2012-08-16 |
| RU2018122965A (ru) | 2019-03-06 |
| RU2664431C2 (ru) | 2018-08-17 |
| NZ701432A (en) | 2016-06-24 |
| BR112013014479B1 (pt) | 2020-10-27 |
| US20160244841A1 (en) | 2016-08-25 |
| SG191078A1 (en) | 2013-07-31 |
| EP2649203B1 (en) | 2019-07-24 |
| US9347090B2 (en) | 2016-05-24 |
| WO2012079010A3 (en) | 2012-08-23 |
| AU2011338210B2 (en) | 2016-05-12 |
| NZ612799A (en) | 2015-04-24 |
| US20130337448A1 (en) | 2013-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103547680B (zh) | 用于确定牙周病的严重性和进展的改进方法和试剂盒 | |
| AU755107B2 (en) | Prediction of inflammatory disease associated with IL-1 geneloci polymorphisms | |
| KR20010024597A (ko) | 만성 폐쇄성 기도 질환에 대한 진단방법 및 치료방법 | |
| JP4492849B2 (ja) | 転写および炎症性疾患および感染症に対する感受性に影響するインターロイキン−１遺伝子座の機能的多型 | |
| EP1996733A2 (en) | Markers for addiction | |
| AU6067900A (en) | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype | |
| US20100092959A1 (en) | Single nucleotide polymorphisms as genetic markers for childhood leukemia | |
| CN101437960A (zh) | 成瘾性的标志物 | |
| AU760856B2 (en) | Diagnostics and therapeutics for chronic obstructive airway disease | |
| MXPA06012744A (es) | Marcadores de haplotipo y metodos para utilizarlos en la determinacion de la respuesta al tratamiento. | |
| WO2005108619A2 (en) | Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype | |
| JP2002330755A (ja) | Ｔｃｆ−１ヌクレオチド配列変異体 | |
| HK1188260B (en) | Improved method for determining severity and progression of periodontal disease | |
| HK1188260A (en) | Improved method for determining severity and progression of periodontal disease | |
| JP6892102B2 (ja) | ウシ白血病ウイルス（ｂｌｖ）プロウイルスロードの判定方法およびその利用 | |
| US20030087798A1 (en) | Atopy-associated sequence variants on chromosome 12 | |
| WO2012145794A1 (en) | Method of determining response to treatment with immunomodulatory composition | |
| Chai et al. | Genetic polymorphisms and periodontitis | |
| US20080057507A1 (en) | Genetic Marker for Prostate Cancer | |
| Klar | Positional Cloning of Disease Causing Genes: A Genetic Study of Obesity, Ichthyosis Prematurity Syndrome and Meniere's Disease | |
| Hu et al. | Schizophrenia susceptibility genes on chromosome 13q32 | |
| MXPA00004381A (en) | Diagnostics and therapeutics for chronic obstructive airway disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180417 Address after: Massachusetts, USA Patentee after: ORIG3N Inc. Address before: Massachusetts, USA Patentee before: Interleukin Genetics Inc. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170524 Termination date: 20211209 |